Literature DB >> 18369390

Alzheimer's disease: epidemiology, genetics, and beyond.

Xiao-Ping Wang1, Hong-Liu Ding.   

Abstract

Alzheimer's disease (AD) is an increasing epidemic threatening public health. Both men and women are susceptible to the disease although women are at a slightly higher risk. The prevalence of AD rises exponentially in elderly people from 1% at age of 65 to approximately 40%-50% by the age of 95. While the cause of the disease has not been fully understood, genetics plays a role in the onset of the disease. Mutations in three genes (APP, PSEN1, and PSEN2) have been found to cause AD and APOE4 allele increases the risk of the disease. As human genomic research progresses, more genes have been identified and linked with AD. Genetic screening tests for persons at high risk of AD are currently available and may help them as well as their families better prepare for a later life with AD.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18369390      PMCID: PMC5552509          DOI: 10.1007/s12264-008-0105-7

Source DB:  PubMed          Journal:  Neurosci Bull        ISSN: 1995-8218            Impact factor:   5.203


  46 in total

Review 1.  Why should primary care physicians know about the genetics of dementia?

Authors:  L E Pinsky; W Burke; T D Bird
Journal:  West J Med       Date:  2001-12

Review 2.  Current knowledge of chromosome 12 susceptibility genes for late-onset Alzheimer's disease.

Authors:  Alessia D'Introno; Vincenzo Solfrizzi; Anna Maria Colacicco; Cristiano Capurso; Margherita Amodio; Orlando Todarello; Antonio Capurso; Patrick G Kehoe; Francesco Panza
Journal:  Neurobiol Aging       Date:  2005-10-27       Impact factor: 4.673

3.  Clinically diagnosed Alzheimer's disease: autopsy results in 150 cases.

Authors:  C L Joachim; J H Morris; D J Selkoe
Journal:  Ann Neurol       Date:  1988-07       Impact factor: 10.422

4.  Alpha2 macroglobulin and the risk of Alzheimer's disease.

Authors:  R C Dodel; Y Du; K R Bales; F Gao; B Eastwood; B Glazier; R Zimmer; B Cordell; A Hake; R Evans; D Gallagher-Thompson; L W Thompson; J R Tinklenberg; A Pfefferbaum; E V Sullivan; J Yesavage; L Alstiel; T Gasser; M R Farlow; G M Murphy; S M Paul
Journal:  Neurology       Date:  2000-01-25       Impact factor: 9.910

Review 5.  Genetics of Alzheimer's disease.

Authors:  M Hutton; J Pérez-Tur; J Hardy
Journal:  Essays Biochem       Date:  1998       Impact factor: 8.000

6.  Family-based association between Alzheimer's disease and variants in UBQLN1.

Authors:  Lars Bertram; Mikko Hiltunen; Michele Parkinson; Martin Ingelsson; Christoph Lange; Karunya Ramasamy; Kristina Mullin; Rashmi Menon; Andrew J Sampson; Monica Y Hsiao; Kathryn J Elliott; Gonül Velicelebi; Thomas Moscarillo; Bradley T Hyman; Steven L Wagner; K David Becker; Deborah Blacker; Rudolph E Tanzi
Journal:  N Engl J Med       Date:  2005-03-03       Impact factor: 91.245

7.  Alpha2-macroglobulin, lipoprotein receptor-related protein and lipoprotein receptor-associated protein and the genetic risk for developing Alzheimer's disease.

Authors:  Candan Depboylu; Frank Lohmüller; Yansheng Du; Matthias Riemenschneider; Alexander Kurz; Thomas Gasser; Ulrich Müller; Richard C Dodel
Journal:  Neurosci Lett       Date:  2006-05-02       Impact factor: 3.046

Review 8.  Causative and susceptibility genes for Alzheimer's disease: a review.

Authors:  A Rocchi; S Pellegrini; G Siciliano; L Murri
Journal:  Brain Res Bull       Date:  2003-06-30       Impact factor: 4.077

Review 9.  Early-life risk factors for Alzheimer disease.

Authors:  Amy R Borenstein; Cathleen I Copenhaver; James A Mortimer
Journal:  Alzheimer Dis Assoc Disord       Date:  2006 Jan-Mar       Impact factor: 2.703

10.  Alzheimer disease in the US population: prevalence estimates using the 2000 census.

Authors:  Liesi E Hebert; Paul A Scherr; Julia L Bienias; David A Bennett; Denis A Evans
Journal:  Arch Neurol       Date:  2003-08
View more
  27 in total

Review 1.  Influence of deep brain stimulation of the subthalamic nucleus on cognitive function in patients with Parkinson's disease.

Authors:  Bin Wu; Lu Han; Bo-Min Sun; Xiao-Wu Hu; Xiao-Ping Wang
Journal:  Neurosci Bull       Date:  2013-12-12       Impact factor: 5.203

Review 2.  Insulin resistance and neurodegeneration: roles of obesity, type 2 diabetes mellitus and non-alcoholic steatohepatitis.

Authors:  Suzanne M de la Monte; Lisa Longato; Ming Tong; Jack R Wands
Journal:  Curr Opin Investig Drugs       Date:  2009-10

3.  Down-regulation of APLP1 mRNA expression in hippocampus of pilocarpine-induced epileptic rats.

Authors:  Cheng Wang; Zi-Li You; Ding-Ding Zhang
Journal:  Neurosci Bull       Date:  2009-06       Impact factor: 5.203

4.  Alzheimer's disease is type 3 diabetes-evidence reviewed.

Authors:  Suzanne M de la Monte; Jack R Wands
Journal:  J Diabetes Sci Technol       Date:  2008-11

5.  Essential involvement of the NMDA receptor in ethanol preconditioning-dependent neuroprotection from amyloid-betain vitro.

Authors:  Robert M Mitchell; Edward J Neafsey; Michael A Collins
Journal:  J Neurochem       Date:  2009-08-19       Impact factor: 5.372

6.  Hepatic ceramide may mediate brain insulin resistance and neurodegeneration in type 2 diabetes and non-alcoholic steatohepatitis.

Authors:  Lascelles E Lyn-Cook; Margot Lawton; Ming Tong; Elizabeth Silbermann; Lisa Longato; Ping Jiao; Princess Mark; Jack R Wands; Haiyan Xu; Suzanne M de la Monte
Journal:  J Alzheimers Dis       Date:  2009       Impact factor: 4.472

7.  Tetrahydroxy stilbene glucoside reduces the cognitive impairment and overexpression of amyloid precursor protein induced by aluminum exposure.

Authors:  Hong-Bo Luo; Jin-Sheng Yang; Xiang-Qun Shi; Xue-Feng Fu; Qi-Dong Yang
Journal:  Neurosci Bull       Date:  2009-12       Impact factor: 5.203

8.  Fewer referrals to Swedish emergency departments among nursing home patients with dementia, comprehensive cognitive decline and multicomorbidity.

Authors:  A G Mamhidir; A Wimo; A Kihlgren
Journal:  J Nutr Health Aging       Date:  2012-10       Impact factor: 4.075

9.  Selective effect of age, Apo e4, and Alzheimer's disease on hippocampal subfields.

Authors:  Susanne G Mueller; Michael W Weiner
Journal:  Hippocampus       Date:  2009-06       Impact factor: 3.899

10.  Nitrosamine exposure exacerbates high fat diet-mediated type 2 diabetes mellitus, non-alcoholic steatohepatitis, and neurodegeneration with cognitive impairment.

Authors:  Suzanne M de la Monte; Ming Tong; Margot Lawton; Lisa Longato
Journal:  Mol Neurodegener       Date:  2009-12-24       Impact factor: 14.195

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.